Table of Contents for the Digital Edition of Pharmacy & Therapeutics - May 2010 Pharmacy & Therapeutics - May 2010 Prescription: Washington Contents Editorial Medication Errors Drugs/Drug News/ New Medical Devices Drug Forecast New Directions for Health Care Law in the U.S. Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder Pharmaceutical Approval Update American College of Cardiology, 59th Annual ScientificSession Author Guidelines Pharmacy & Therapeutics - May 2010 Pharmacy & Therapeutics - May 2010 - Pharmacy & Therapeutics - May 2010 (Page Cover1) Pharmacy & Therapeutics - May 2010 - Prescription: Washington (Page A2) Pharmacy & Therapeutics - May 2010 - Prescription: Washington (Page A3) Pharmacy & Therapeutics - May 2010 - Prescription: Washington (Page A4) Pharmacy & Therapeutics - May 2010 - Prescription: Washington (Page A5) Pharmacy & Therapeutics - May 2010 - Prescription: Washington (Page A6) Pharmacy & Therapeutics - May 2010 - Prescription: Washington (Page 239) Pharmacy & Therapeutics - May 2010 - Contents (Page 240) Pharmacy & Therapeutics - May 2010 - Contents (Page 241) Pharmacy & Therapeutics - May 2010 - Contents (Page 242) Pharmacy & Therapeutics - May 2010 - Editorial (Page 243) Pharmacy & Therapeutics - May 2010 - Editorial (Page 244) Pharmacy & Therapeutics - May 2010 - Medication Errors (Page 245) Pharmacy & Therapeutics - May 2010 - Drugs/Drug News/ New Medical Devices (Page 248) Pharmacy & Therapeutics - May 2010 - Drugs/Drug News/ New Medical Devices (Page 249) Pharmacy & Therapeutics - May 2010 - Drugs/Drug News/ New Medical Devices (Page 250) Pharmacy & Therapeutics - May 2010 - Drugs/Drug News/ New Medical Devices (Page 251) Pharmacy & Therapeutics - May 2010 - Drugs/Drug News/ New Medical Devices (Page 252) Pharmacy & Therapeutics - May 2010 - Drugs/Drug News/ New Medical Devices (Page 253) Pharmacy & Therapeutics - May 2010 - Drugs/Drug News/ New Medical Devices (Page 254) Pharmacy & Therapeutics - May 2010 - Drug Forecast (Page 261) Pharmacy & Therapeutics - May 2010 - Drug Forecast (Page 262) Pharmacy & Therapeutics - May 2010 - Drug Forecast (Page 263) Pharmacy & Therapeutics - May 2010 - Drug Forecast (Page 264) Pharmacy & Therapeutics - May 2010 - Drug Forecast (Page 265) Pharmacy & Therapeutics - May 2010 - Drug Forecast (Page 266) Pharmacy & Therapeutics - May 2010 - Drug Forecast (Page 267) Pharmacy & Therapeutics - May 2010 - Drug Forecast (Page 268) Pharmacy & Therapeutics - May 2010 - Drug Forecast (Page 269) Pharmacy & Therapeutics - May 2010 - New Directions for Health Care Law in the U.S. (Page 270) Pharmacy & Therapeutics - May 2010 - New Directions for Health Care Law in the U.S. (Page 271) Pharmacy & Therapeutics - May 2010 - New Directions for Health Care Law in the U.S. (Page 272) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 273) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 274) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 275) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 276) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 277) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 278) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 279) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 280) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 281) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 282) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 283) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 284) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 285) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 286) Pharmacy & Therapeutics - May 2010 - Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (Page 287) Pharmacy & Therapeutics - May 2010 - Pharmaceutical Approval Update (Page 288) Pharmacy & Therapeutics - May 2010 - Pharmaceutical Approval Update (Page 289) Pharmacy & Therapeutics - May 2010 - Pharmaceutical Approval Update (Page 290) Pharmacy & Therapeutics - May 2010 - American College of Cardiology, 59th Annual ScientificSession (Page 291) Pharmacy & Therapeutics - May 2010 - American College of Cardiology, 59th Annual ScientificSession (Page 292) Pharmacy & Therapeutics - May 2010 - American College of Cardiology, 59th Annual ScientificSession (Page 293) Pharmacy & Therapeutics - May 2010 - American College of Cardiology, 59th Annual ScientificSession (Page 294) Pharmacy & Therapeutics - May 2010 - Author Guidelines (Page 295) http://www.nxtbook.com/nxtbooks/medimedia/pt_201202 http://www.nxtbook.com/nxtbooks/medimedia/pt_201201 http://www.nxtbook.com/nxtbooks/medimedia/pt_201112 http://www.nxtbook.com/nxtbooks/medimedia/pt_201111 http://www.nxtbook.com/nxtbooks/medimedia/pt_201110 http://www.nxtbook.com/nxtbooks/medimedia/pt_201109 http://www.nxtbook.com/nxtbooks/medimedia/pt_201108 http://www.nxtbook.com/nxtbooks/medimedia/pt_201107 http://www.nxtbook.com/nxtbooks/medimedia/pt_201106 http://www.nxtbook.com/nxtbooks/medimedia/pt_201105 http://www.nxtbook.com/nxtbooks/medimedia/pt_201104 http://www.nxtbook.com/nxtbooks/medimedia/pt_201103 http://www.nxtbook.com/nxtbooks/medimedia/pt_201102 http://www.nxtbook.com/nxtbooks/medimedia/pt_201101 http://www.nxtbook.com/nxtbooks/medimedia/pt_201012 http://www.nxtbook.com/nxtbooks/medimedia/pt_201011 http://www.nxtbook.com/nxtbooks/medimedia/pt_201010 http://www.nxtbook.com/nxtbooks/medimedia/pt_201009 http://www.nxtbook.com/nxtbooks/medimedia/pt_201008 http://www.nxtbook.com/nxtbooks/medimedia/pt_201007 http://www.nxtbook.com/nxtbooks/medimedia/pt_201006 http://www.nxtbook.com/nxtbooks/medimedia/pt_201005 http://www.nxtbook.com/nxtbooks/medimedia/pt_201004 http://www.nxtbook.com/nxtbooks/medimedia/pt_201003 http://www.nxtbook.com/nxtbooks/medimedia/pt_201002 http://www.nxtbook.com/nxtbooks/medimedia/pt_201001 http://www.nxtbook.com/nxtbooks/medimedia/pt_200912 http://www.nxtbook.com/nxtbooks/medimedia/pt_200911 http://www.nxtbook.com/nxtbooks/medimedia/pt_200910 http://www.nxtbook.com/nxtbooks/medimedia/pt_200909 http://www.nxtbook.com/nxtbooks/medimedia/pt_200908 http://www.nxtbook.com/nxtbooks/medimedia/pt_200907 http://www.nxtbook.com/nxtbooks/medimedia/pt_200906 http://www.nxtbook.com/nxtbooks/medimedia/pt_200905 http://www.nxtbook.com/nxtbooks/medimedia/pt_200904 http://www.nxtbook.com/nxtbooks/medimedia/pt_200903 http://www.nxtbook.com/nxtbooks/medimedia/pt_200902 http://www.nxtbook.com/nxtbooks/medimedia/pt_200901 http://www.nxtbook.com/nxtbooks/medimedia/pt_200812 http://www.nxtbook.com/nxtbooks/medimedia/pt_200811 http://www.nxtbook.com/nxtbooks/medimedia/pt_200810 http://www.nxtbook.com/nxtbooks/medimedia/pt_200809 http://www.nxtbook.com/nxtbooks/medimedia/pt_200808 http://www.nxtbook.com/nxtbooks/medimedia/pt_200807 http://www.nxtbook.com/nxtbooks/medimedia/pt_200806 http://www.nxtbook.com/nxtbooks/medimedia/pt_200805 http://www.nxtbook.com/nxtbooks/medimedia/pt_200804 http://www.nxtbook.com/nxtbooks/medimedia/pt_200803 http://www.nxtbook.com/nxtbooks/medimedia/pt_200802 http://www.nxtbook.com/nxtbooks/medimedia/pt_200801 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.